Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Completed

Conditions studied: Allergic Asthma

In brief

This study will establish a clinical data and serum repository of anaphylaxis cases associated with Xolair administration and control patients who have received Xolair without associated anaphylaxis. This is an observational repository and not an investigational clinical trial. Associated with the repository is an optional skin testing substudy.

Key facts

Study ID

NCT00813748

Run by

Genentech, Inc.

People needed

118

Starts

2009-03-01

Expected to finish

2014-01-01

Last updated by the study team

2017-07-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Investigational Site — Los Angeles, California, United States
• Investigational Site — Valrico, Florida, United States
• Investigational Site — Hinsdale, Illinois, United States
• Investigational Site — Kansas City, Missouri, United States
• Investigational Site — New York, New York, United States
• Investigational Site — Blue Bell, Pennsylvania, United States
• Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.